Exogenus Therapeutics

Cantanhede, Portugal

Exogenus Therapeutics develops cellular based therapies applied to regenerative medicine for skin lesions treatment.

Apr 2026

Grant

Biotechnology Medical Therapeutics

Top Investors

EIC Accelerator EISMEA Caixa Capital maze impact 3xP Global

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Exogenus Therapeutics

Who are Exogenus Therapeutics's investors?

Exogenus Therapeutics's investors include EIC Accelerator, EISMEA, Caixa Capital, maze impact, 3xP Global.

Where is Exogenus Therapeutics headquartered?

Exogenus Therapeutics is headquartered in Cantanhede, Portugal.

What does Exogenus Therapeutics do?

Exogenus Therapeutics develops cellular based therapies applied to regenerative medicine for skin lesions treatment.

What stage is Exogenus Therapeutics at?

Exogenus Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 23, 2026.

MLA

"Exogenus Therapeutics — Funding & Investors." VCBacked, April 23, 2026, https://www.vcbacked.co/company/exogenus-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2026). Exogenus Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/exogenus-therapeutics

Wikipedia (cite web)

{{cite web |title=Exogenus Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/exogenus-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 23, 2026.